Skip to main content

TSE:TOS - TSO3 Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.00
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New TSO3 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TOS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TOS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$0.00
This price target is based on 0 analysts offering 12 month price targets for TSO3 in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in TSO3. This rating has held steady since March 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/18/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/31/2019DesjardinsReiterated RatingHold
i
Rating by F. Tremblay at Desjardins
1/9/2019Echelon Wealth PartnersReiterated RatingBuy
i
Rating by D. Loe at Echelon Wealth Partners
12/20/2018National Bank FinancialReiterated RatingSector PerformC$1.25
i
11/8/2018Royal Bank of CanadaLower Price TargetSector PerformC$0.90 ➝ C$0.80
i
8/9/2018Royal Bank of CanadaLower Price TargetSector PerformC$1.50 ➝ C$0.90
i
8/9/2018DesjardinsLower Price TargetC$1.25 ➝ C$1.10
i
8/2/2018National Bank FinancialLower Price TargetSector PerformC$1.50 ➝ C$1.25
i
5/10/2018National Bank FinancialLower Price TargetSector PerformC$1.75 ➝ C$1.50
i
Rating by E. Leno at National Bank Financial
5/10/2018Canaccord GenuityLower Price TargetC$2.40 ➝ C$2.00
i
5/10/2018DesjardinsLower Price TargetC$1.60 ➝ C$0.90
i
Rating by F. Tremblay at Desjardins
5/3/2018Royal Bank of CanadaLower Price TargetSector PerformC$1.75 ➝ C$1.50
i
3/22/2018National Bank FinancialLower Price TargetSector PerformC$2.25 ➝ C$1.75
i
Rating by E. Leno at National Bank Financial
3/22/2018DesjardinsLower Price TargetHoldC$2.00 ➝ C$1.60
i
Rating by F. Tremblay at Desjardins
3/13/2018Royal Bank of CanadaLower Price TargetSector PerformC$2.00 ➝ C$1.75
i
1/30/2018ScotiabankLower Price TargetOutperformC$4.50 ➝ C$2.75
i
1/29/2018National Bank FinancialDowngradeOutperform ➝ Sector PerformC$5.50 ➝ C$2.25
i
Rating by E. Leno at National Bank Financial
1/26/2018DesjardinsDowngradeBuy ➝ Hold
i
Rating by F. Tremblay at Desjardins
1/26/2018Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformC$4.25 ➝ C$2.00
i
1/26/2018Canaccord GenuityDowngradeBuy ➝ Speculative BuyC$4.25 ➝ C$2.75
i
10/18/2017DesjardinsReiterated RatingBuyC$4.00
i
Rating by F. Tremblay at Desjardins
7/6/2017ScotiabankReiterated RatingOutperformC$4.50
i
6/26/2017Canaccord GenuityReiterated RatingBuyC$5.25
i
6/15/2017Royal Bank of CanadaReiterated RatingOutperform
i
5/3/2017Royal Bank of CanadaReiterated RatingOutperformC$4.25
i
10/20/2016National Bank FinancialReiterated RatingOutperformC$5.50
i
Rating by E. Leno at National Bank Financial
9/12/2016Paradigm CapitalSet Price TargetBuyC$5.50
i
7/27/2016DesjardinsReiterated RatingBuyC$5.50
i
Rating by M. Jarvi at Desjardins
7/6/2016LaurentianBoost Price TargetC$3.25 ➝ C$5.00
i
7/6/2016Laurentian Bank of CanadaBoost Price TargetC$3.25 ➝ C$5.00
i
7/5/2016Canaccord GenuityBoost Price TargetBuyC$3.50 ➝ C$5.25
i
6/24/2016Canaccord GenuityBoost Price TargetBuyC$3.25 ➝ C$3.50
i
6/13/2016GMP SecuritiesReiterated RatingBuy
i
(Data available from 5/16/2016 forward)
TSO3 logo
TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. The company also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. In addition, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada.
Read More

Today's Range

Now: N/A

50 Day Range

MA: C$0.43
C$0.43
C$0.43

52 Week Range

Now: N/A

Volume

76,925 shs

Average Volume

235,811 shs

Market Capitalization

C$40.21 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of TSO3?

The following Wall Street sell-side analysts have issued reports on TSO3 in the last year:
View the latest analyst ratings for TOS.

What is the current price target for TSO3?

0 Wall Street analysts have set twelve-month price targets for TSO3 in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for TSO3 in the next year.
View the latest price targets for TOS.

What is the current consensus analyst rating for TSO3?

TSO3 currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for TOS.

What other companies compete with TSO3?

How do I contact TSO3's investor relations team?

TSO3's physical mailing address is 2505 Dalton Ave, QUEBEC, QC G1P 3S5, Canada. The company's listed phone number is +1-418-6510003. The official website for TSO3 is www.tso3.com.